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Abstract
Background: Rheumatoid arthritis, disease of unknown causes is a rheumatic and autoimmune pathology,
recognised for its increasing frequency and its adverse consequences. It is a disease that occurs in most
cases between 50 and 60 years and women are more affected than men. This study aimed at evaluating
immunomodulatory and anti-arthritis capacity of aqueous and methanol extracts of stem bark of Piptadeniastrum
africanum (Mimosaceae).
Methods: ROS production from phagocytes, proliferation of T-cells, TNF-α and IL-1β production and cytotoxicity
were performed by using chemiluminescence technique, liquid scintillation counter, ELISA and MTT assay,
respectively. Anti-arthritic activity was evaluated using a model of adjuvant induced arthritis.
Results: Methanol and aqueous extracts of Piptadeniastrum africanum significantly (P < 0.001) inhibited extracellular and
intracellular ROS production. These extracts also possess significant (P < 0.001) inhibitory activity on T-cell proliferation
other than reduced TNF-α and IL-1β production. Piptadeniastrum africanum also significantly exhibited antiarthritic
activity in complete Freund’s adjuvant induced arthritis in rat associated with a significant anti-inflammatory and anti-
hyperalgesia activity.
Conclusions: Immunomodulatory, anti-inflammatory, antihyperalgesia and anti-arthritis potential revealed in this study
approve that, Piptadeniastrum africanum is a plant rich in compounds with anti-arthritic properties.
Keywords: Piptadeniastrum africanum, Immunomodulation, Oxidative burst, T-cell proliferation, Cytotoxicity,
Rheumatoid arthritis
Background
Rheumatoid arthritis (RA), that affects between 0.3 and
1% people in the world, is considered as a chronic and
debilitating pathology, and globally as a most frequent
inflammatory rheumatic disease. The disease appears in
most cases between 50 and 60 years of age and women
are more affected than men [1, 2]. It affects life and
limits the movement of people [3, 4]. In people with RA,
a deformation of joints is observed with increased in vol-
ume and loss of function, cartilage and bone destruction;
these people suffer with a remarkable reduction of daily
life quality which can lead to depression [5]. This disease
mainly affects the ankle joint resulting in a gradual pain-
ful swelling, exaggerated and abnormal development of
the synovium, pannus formation and changes in the
morphology of the joint. [5, 6] RA progresses in three
stages: swelling, warmth, pain and redness around the
joint due to the swelling of the synovial membrane;
thickening of the synovial membrane due to the division
and the rapid growth of cells or pannus; release of en-
zymes by the inflamed cells that can digest bone and
* Correspondence: mbiantchamarius@yahoo.fr; almas79_jabeen@yahoo.com
1Laboratory of Animal Physiology and Phytopharmacology, Faculty of
Science, University of Dschang, P.O. Box 67, Dschang, Cameroon
2Dr. Panjwani Center for Molecular Medicine and Drug Research,
International Center for Chemical and Biological Sciences, University of
Karachi, Karachi 75270, Pakistan
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Mbiantcha et al. BMC Complementary and Alternative Medicine  (2017) 17:111 
DOI 10.1186/s12906-017-1623-5
cartilage resulting in loss of shape and alignment of the
joint involved with more pain and loss of motion [7].
Immunology holds a dominant role in the understand-
ing of rheumatic diseases [8]. In rheumatoid synovium,
we note the presence of monocytes, mast cells, macro-
phages, polymorphonuclear cells and fibroblast synovio-
cytes [9, 10]. Activated macrophages and synoviocytes
will secrete large amounts of proteases, cytokines IL-1β
and TNF-α [11]. These cytokines are strong pro-
inflammatory mediators in the cascades of information
transmission between inflammatory cells in RA synovitis
[12]. IL-1β and TNF-α play a particularly important role
by causing the liberation of metalloproteases (collage-
nases, stromelysin) and prostaglandins (PGE2) by acti-
vated cells (fibroblastes, macrophages, synovial dendritic
cells) [13]. This causes destruction of cartilage tissue,
bone resorption and chronic proliferation of synovio-
cytes cells [14]. IL-1β and TNF-α have synergistic effects
in aggravating the inflammation, so by inhibiting TNF-α,
we can block or reduce the activity of IL-1β [11]. TNF-α
appears as the cytokine of inflammation but is also cap-
able of inducing cartilage lesions, while IL-1β which is
also important in inflammation, appears especially as the
cytokine responsible of cartilage lesions and delays heal-
ing of lesions [15]. TNF-α also induces the release of
other cytokines as IL-6 (inducer of the hepatic acute
phase response) and IL-8 (chemotactic factor for neutro-
phils), which puts TNF-α at the head of processes
including pro-inflammatory cytokines [15]. The major
role of these mediators in the immunopathology of RA
has led to the elaboration and the use of targeted
therapies anti-TNF-α and anti-IL-1β [14]. Otherwise, in
RA, oxidative stress is recognized as an important
parameter in pathogenicity with oxygen radicals which
are factors involved in tissue destruction [16, 17]. In the
inflamed or painful joints, macrophages, chondrocytes
and neutrophils can produce the ROS (reactive oxygen
species) [18].
The evaluation of a drug that can prevent the cause of
arthritis or act during the stages of installation of arth-
ritis requires the use of an evaluation model that pro-
duced in animals the same type of arthritis in humans
[19]. The evaluation that the different classes of com-
pounds having anti-arthritic activity in clinical use re-
quires the use of appropriate animal models. However,
the choice of the model needs not only the morpho-
logical similarities to human diseases, but also the ability
of the model to predict the effectiveness of treatment in
humans [19, 20]. The pathophysiological study, pharma-
cological control of inflammatory processes, analgesic,
anti-inflammatory and/or antiarthritis effects of drugs
can be evaluated after injection of complete freund’s
adjuvant on rat [21], it is also widely used in the evalu-
ation of systemic changes observed in chronic
inflammation [22], using the CFA model induced arth-
ritis on rat in experimental research is justified by the
fact that therapeutic compounds active in this model are
also active for the vast majority of humans with RA [23].
Based on the fact that, human civilization uses natural
products with therapeutic properties for many decades,
it is obvious that, medicinal plants offer a real and per-
manent solution to many health problems. Today, the
modulation of the immune response by various natural
products as well as by compounds obtained through
chemical synthesis have already been demonstrated by
many researchers [24, 25]. Inflammatory mediators, in-
cluding cytokines and free radicals play a vital role in
many diseases, putting inflammation and oxidative stress
at the center of many pathological conditions, among
the most frequent health problems in the world which
include the dysfunction of the immune system (RA, ath-
erosclerosis, inflammatory disease, diabetes and neuro-
degenerative disorders) [26]. It is therefore necessary to
find new therapeutic approaches that target the inflam-
matory parameters mainly involved in the pathogenesis
of the disease [27].
Piptadeniastrum africanum (P. africanum) belong to
the family Mimosaceae. In Cameroon, it is used for the
management of constipation, anaemia, lumbago, menin-
gitis, pains, edema, rheumatism, convulsion, gastric ulcer
and wound treatment [28–30]. Several plant extracts be-
longing to the Mimosaceae family showed anti-arthritic
properties. These include Acacia auriculiformis [26],
Acacia polyantha [31] and Albizia lebbeck [32]. Previous
works have shown that, P. africanum possesses antibac-
terial properties and has no toxicological effects under
the threshold of 5 mg/kg in rat [33, 34]. Previous studies
have also reported that, the stem bark of P. africanum
given orally to rats, possesses gastro-protective and ulcer
healing properties [35], antiproliferative [36] and antino-
ciceptive activities, as well as anti-inflammatory proper-
ties of the model of chronic inflammation induced by
formalin [37]. Recent phytochemical studies on the root
of P. africanum have revealed the presence of flavonoids,
alkaloids, steroids, triterpenoids and saponins [36, 38].
Several of these chemical compounds have already
shown their interesting effect both in immunomodula-
tion and in the treatment of rheumatoid arthritis in-
duced by CFA [39, 40].
CFA induced RA model on rat is a chronic inflamma-
tion including multiple systemic change with synovial
hyperplasia resulting from a great proliferative cellular
infiltrate of leukocytes and an abnormal increase in
levels of many cytokines (particularly IL-1β and TNF-α),
significant release of ROS and consequent cartilage and
bone destruction with swelling, deformation and loss of
function of joint. [18, 41] Based on the fact that, the
stem bark of P. africanum possess anti-inflammatory
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properties on chronic inflammatory model, and the fact
that preliminary in vitro assay have shown the suppres-
sive properties of the production of pro inflammatory
cytokines, antiproliferative properties and inhibiting
ROS production, we chose in our study in vivo, to deter-
mine the anti-arthritic properties of this plant using the
model of arthritis induced by CFA on rat.
In this study, we firstly describe in vivo, anti-
inflammatory, antihyperalgesia and antiarthritis effects
of stem bark of P. africanum (aqueous and methanol
extracts) and its significant effect on systemic changes,
and secondly, in vitro studies to evaluate immunomod-
ulatory, antiproliferative and cytotoxic effects. Both
extracts were analysed for their inhibitory property on
intra and extracellular ROS as well as cytokines
production.
Methods
Reagents, chemicals, and equipments
Lymphocytes Separation Medium, Luminol, Indometh-
acin as Hanks Balance Salts Solution and Lucigenin were
obtained from MP Biomedicals Inc., Research Organics
and Sigma ; Dimethylsulphoxide, ethanol and ammo-
nium chloride of analytical grades from Merck Chemi-
cals, Darmstadt, Germany; Zymosan A as Phorbol
myristate acetate from Fluka and Human monocytic
leukemia cells from European Collection of Cell Cul-
tures; human TNF-α and IL-1β ELISA Kit from R&D
systems, Minneapolis, USA and glass fiber filter and cell
harvester from INOTECH, Dottikon, Switzerland.
Experimental animals
In the present study, female Wistar rats (150–200 g, 10
to 12 weeks of age) were used. Animal house of H.E.J.
Research Institute of Chemistry, International Center for
Chemical and Biological Sciences (ICCBS), University of
Karachi, Pakistan, provided all the animals. During 1
week acclimatization (22 ± 1 °C temperature and 50–
80% humidity), with 12 h cycle variation between the
light and dark, freely, animals consumed a standard diet
for rodents and water filtered beforehand. The coher-
ence of the effects of administered treatments were
determined using a minimum possible number of rats.
The treatment of animals was in agreement with the In-
stitutional Animal Care, Use and Standards Committee
(IACUC) of ICCBS were followed (Protocol No.
1209004), and the study protocols accepted by the
ethics committee of ICCBS were followed, University
of Karachi, Pakistan.
Collection and preparation of plant material
P. africanum (Hook. f.), collected from the district of
Bokito in Cameroon (Central Region), authenticated by
referring to other specimens (N° 12115/SRF) preserved
at the Cameroon National Herbarium (Yaounde), was
used for this study. After collection of fresh stem bark of
P. africanum, they were cut into small pieces, dried out
of the sun and then crushed into a fine powder.
Plant material
Aqueous extract: 560 g of P. africanum stem bark pow-
der was mixed with distilled water (3 l), the mixture was
wormed to boil (20 min, decoction), cooled (30 min) at
room temperature followed by filtration (Whatman filter
paper no.1) and evaporation (drying oven set at 40 °C)
afforded 19.72 g (3.25% yields) of aqueous extract.
Methanol extract was obtained by maceration of 200 g
of powder in 1.5 l of methanol for 72 h. Filtration
(Whatman filter paper) of the mixture followed the
concentration of the filtrate (rotary evaporator, 65 °C)
afforded 18.81 g (28.08% yields) of methanol extract.
In vitro assays
Isolation of human polymorpho neutrophils (PMNs)
Ten milliliters of venous blood obtained aseptically from
a healthy volunteer donor (31 years of age) were intro-
duced into a tube containing heparin as an anticoagu-
lant. The method of Ficoll hypaque density gradient
centrifugation was used to isolated neutrophils [42].
Briefly, on a 45 ml empty centrifuge tube, whole blood,
lymphocytes separation medium (LSM) and HBSS were
mixed in equal volumes. After 30 min, the supernatant
was sampled and slowly introduced into empty centri-
fuge tubes of 15 ml containing 5 ml of lymphocytes
separation medium (LSM) and centrifuged (400 g, 20
min, room temperature). After discarding the super-
natant, distilled water (1 ml) was added to the pellet
for exactly one minute for the lysis of RBCs and 1 ml
of HBSS−−(2x) was then added to stop the lysis. Then
5 ml of HBSS was again added to the tubes and the
tubes were centrifuged (300 g, 10 min, 4°C), discarded
the supernatant and introduced again HBSS−− (1ml)
and stored (in ice). Trypan blue exclusion method was
used to check the viability and the cells counted by
haemocytometer. A cell concentration of 1 × 106 cells/ml
was used for tests.
Peritoneal macrophages isolation from mice
NMRI mice (18 – 25 g), immunized with FBS (1 ml)
injected intraperitoneally using sterile 1 ml syringe, were
kept for 72 h in the animal house and killed by cervical
dislocation. 10 ml of 10% RPMI medium was injected in
the peritoneum cavity after sterilizing whole animal bod-
ies by dipping into 70% ethanol. Peritoneum cavity was
then massaged for 2 min and the abdominal skin was
cut from the lower side and retracted to expose periton-
eum cavity. The injected RPMI containing macrophage
was collected with the help of a sterile syringe from
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peritoneum, then centrifuged for 20 min (400 g, 4°C).
After discarding the supernatant, the pellet was washed
with incomplete RPMI media, then centrifuged for 10 min
(300 g, 4 °C), then added 1 ml of incomplete RPMI media/
HBSS. Trypan blue exclusion method was used to check
viability and count cell by haemocytometer, a cell concen-
tration of 1 × 106 cells/ml was used for tests [43, 44].
Chemiluminescence assay
Chemiluminescence test was done as described previ-
ously with modifications [43, 44]. White plates 96 wells
were used for testing. 25 μl of plant extracts (3.1 to 100
μl/ml) or ibuprofen were mixed with 25 μl of whole
blood (diluted in HBSS++ (1:50)) or PMNs (1 × 106) or
macrophages (2 × 106) cells, except for control wells that
received only the HBSS++ and cells without extract.
After 20 min incubation of plates at 37°C (thermostated
chamber of Luminometer), to reach 100 μl volume/well,
25 μl of Serum Opsonized Zymosan/PMA and/or 25 μl
of luminol/lucigenin (7 × 105 M) were added. The re-
sults of this test were obtained as Relative light units
(RLU) [44]. The following formula was used to calculate
inhibition percentage (%) for each compound:
Inhibition %ð Þ ¼ RLUcontrol– RLUsample
   100 %
RLUcontrol
Cytokine assay
To maintain THP-1 (Human monocytic leukemia cells),
endotoxin free RPMI1640 was used. The cultivated cells
(2.5 × 105 cells/ml) in 75cc flasks up to 70% confluence
were introduced into 24 wells tissue culture plates. PMA
was used for differentiated cells into macrophage like cells
(20 ng/ml) and incubated for 24 h at 37 °C in 5% CO2. E.
coli Lipopolysacchride B was used to stimulate cells (50
ng/ml), treated with extracts (50, 10 and 2 μg/ml), plate
were incubated (4 h, 37 °C) in CO2 (5%). Finally the super-
natants was collected to analyze the level cytokines using
human TNF-α and IL-1β ELISA Kit [45].
T-Cell proliferation assay [41]
Briefly, in white 96 wells round bottom plates, 50 μl of ex-
tract (2, 10 and 50 μg/ml) or prednisolone diluted in 5%
RPMI were introduced. Each dilution were triplicated,
then 50 μl of isolated T-cells (2 × 106 cells/ml) were added
and stimulated with 50 μl of phytohemagglutinin-L
(PHAL) (7.5 μg/ml). Negative control wells received only
cells (50 μl) and 5% RPMI (150 μl) and positive control re-
ceived cells (50 μl), PHA (50 μl) and 5% RPMI (100 μl).
After the incubation of plates (72 h, 37 °C) in CO2 (5%) in-
cubator, 25 μl of 0.5 μCi/well (methyl 7 3H) thymidine
were used to pulse the cultures, then plates were further
incubated (18 h) and glass fiber filter was used to harvest
the cells. LS65000 liquid scintillation counter was used to
determine the level of the thymidine integrated into the
cells. Percent inhibition was determined by using the
counts per minute (CPM) of each well according to the
formula:
Inhibitory activity %ð Þ ¼ CPM Control groupð Þ– CPM Experiment groupð Þ
CPM Control groupð Þ
100
MTT Cytotoxicity assay
In vitro cytotoxicity of extracts was evaluated by MTT
assay described by Scholz et al. [46]. 96 welled flat bot-
tom plates containing 100 μl of cell suspension (6 × 104
cells/ml) were incubated (24 h, 37 °C) in CO2 (5%). After
removing the media in each well, extracts (3.1–100 μg/
ml) and complete DMEM were added (200 μl final vol-
ume). Positive control wells contained cells (100 μl) and
complete DMEM and in negative control 0.5% triton
X100 (2 μl) were add. After incubation (48 h, 37 °C) in
CO2 incubator, the supernatant was removed, MTT (50
μl, 0.5 mg/ml) diluted in PBS (5 mg/ml) added and
plates were incubated again (4 h). MTT was carefully
aspirated and DMSO (100 μl) was added with agita-
tion (10–15 min) in an orbital shaker. The spectro-
photometer was used at 540 nm for absorbance. The
percent inhibition or decrease in cells viability was
obtained the formula:




Induction of AIA (adjuvant induced arthritis)
To induce arthritis, animals were first anesthetized with
a small amount of ether vapor, then 100 μl of freshly
prepared CFA (10 mg/ml) dissolved in mineral oil
(sterile) was injected delicately into the hindpaw [47].
Normal animals received 100 μl of sterile mineral oil.
Treatment regimen
After classifying and grouping animals according to their
weight, each animal was marked by the tail with a num-
ber and placed in a cage with a letter identifying the
cage. By this process, 42 female rats were distributed
into 7 groups (6 rats each). Group 1 (healthy control) re-
ceived no treatment and no injection of CFA, Group 2
(arthritis control) received vehicle (5% DMSO + PBS)
with CFA injected in the paw, Group 3 (positive control)
received indomethacin (5 mg/kg) with CFA injected in
the paw, Groups 4 and 5 received aqueous extract of P.
africanum (200 and 400 mg/kg) with CFA injected in
the paw, Groups 6 and 7 methanol extracts of P.
africanum (200 and 400 mg/kg) with CFA injected in
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the paw. All treatments was administered orally thirty
minutes before CFA induction (day 0), then the animals
were treated daily for up to 19th days.
Measurement of paw volume, joint diameter, arthritic score,
pain threshold, thermal hyperalgesia and body weight
The severity of arthritis was evaluated on day 0, 1, 3, 5,
7, 9, 11, 13, 15, 17 and 19. For this purpose, Plethysm-
ometer (UGO Basile, Italy) was used to measure paw
volume [48]. Digital Vernier caliper (Mitutoyo, Japan)
was used to measure joint diameter [49]. Randall Selitto
analgesiometer (UGO Basile, Italy) was used to measure
mechanical pain threshold [50] and plantar test appar-
atus (Ugo Basile, Comerio, Italy) was used to measure
thermal hyperalgesia [51]. For each animal, variation of
edema, joint diameter, paw withdrawal latency responses
(pain threshold) and paw withdrawal latencies (thermal
hyperalgesia) were expressed as % values relative to the
pre-administration value (100%) [52]. Evaluation of the
degree of arthritis was assessed daily by visual observa-
tion. A score of 0–4 helped distinguish the different dis-
ease stages with a maximum value of 8 for each rat.
Scores was attributed according to the parameters such
as edema, erythema, malformation and incapacity to use
the limb [53]. Body weight was recorded with the aid of
a balance.
Measurement of organs weight and Biochemical estimations
On day 20, after anesthesia (using anesthetic ether), car-
diac puncture was used to draw blood and introduce
into a tube containing EDTA as anticoagulant and into
another tube without anticoagulant; then liver, kidney,
thymus and spleen were removed delicately and
weighed. Hematological parameters like erythrocytes
(RBC) and leukocytes (WBC) counts, hemoglobin (Hb),
Hematocrit and platelets (PLT) were determined in
blood with anticoagulant by the usual standardized la-
boratory method [54]. Otherwise, blood without anti-
coagulant was centrifuged for 5 min (4900 rpm) and the
serum was collected, then serum AST, ALT, ALP, total
protein, C-reactive protein (CRP) and Rheumatoid factor
(RF) levels was also quantified [55].
Histopathological analysis of ankle joints
After sacrifice, the animal knee joints were removed and
preserved in 10% formalin + PBS. After fixation and
decalcification, sample was cut into 45 μm pieces, then
hematoxylin and eosin (H & E) for microscopic evalu-
ation [56].
Statistical analysis
Mean ± standard Error of Mean (SEM) was used to ex-
press the results of the study. For statistical analysis,
multiple comparisons of data were carried out using two
and one way analysis of variance (ANOVA), and then
post test of Tukey was used for post hoc analysis.
Significance was statistically acceptable at a level of P <




Effect of P. africanum extracts on intracellular ROS production
To evaluate myeloperoxidase dependent effect of ex-
tracts, luminol was used as probe. On human whole
blood phagocytes, results showed that, extracts of P.
africanum (3.1–100 μg/ml) possess significant inhibitory
activity on intracellular ROS production; with IC50
values of 10.04 μg/ml (aqueous extract) and 4.02 μg/ml
(methanol extract) (Table 1).
Concerning neutrophils, the extracts also showed po-
tent inhibitory effect with an IC50 value of 2.29 μg/ml
(methanol extract) and 8.68 μg/ml (aqueous extract)
(Table 1); when tested on ROS produced from the mice
peritoneal macrophages, methanol extract caused signifi-
cant inhibitory activity (IC50 = 2.85 μg/ml), while aque-
ous extract shows an IC50 of 11.64 μg/ml (Table 1).
Ibuprofen, used as reference product, showed an IC50 of
12.97 and 13.93 μg/ml, respectively for neutrophils and
mice peritoneal macrophages.
Effect of P. africanum extracts on extracellular ROS
production
Myeloperoxidase independent effect was studied using
lucigenin as probe. The results showed that, on whole
blood, neutrophils and macrophages, both methanol and
aqueous extracts exhibited significant inhibition of ROS.
The IC50 values observed were 4.89 and 8.59 μg/ml, re-
spectively for methanol and aqueous extracts on whole
blood, compared to the ibuprofen (IC50 = 13.73 μg/ml)
(Table 1). When tested on neutrophils, extracts showed
significant inhibitory activity with 2.96 and 5.74 μg/ml as
IC50 respectively for methanol and aqueous extracts
(Table 1). Similarly on mice macrophages methanol ex-
tract showed a potential inhibitory effect (IC50 = 2.80μg/
ml), followed by aqueous extract (IC50 = 11.85 μg/ml)
compared to ibuprofen (IC50 = 14.30 μg/ml) (Table 1).
Effect of P. africanum extracts on Production of Pro-
Inflammatory Cytokines
The effect of extracts on the release of TNF-α and IL-1β
by activated THP-1 cells was evaluated with concentra-
tions of 2–50 μg/ml of the extracts (Fig. 1). The metha-
nol extract of P. africanum significantly (P < 0.01)
decreased the level of TNF-α and IL-1β with 36.4% and
28.7% inhibitions respectively. On cytokines production,
control samples and aqueous extract treated samples did
not show any significant (P > 0.05) variations.
Mbiantcha et al. BMC Complementary and Alternative Medicine  (2017) 17:111 Page 5 of 16
Effect of P. africanum extracts on T-Cell proliferation assay
On this assay, both extracts showed a notable level of
antiproliferative effect, methanol extract caused the
maximum inhibition with IC50 < 1 μg/ml, whereas aque-
ous extract showed a moderate level of antiproliferative
effect with an IC50 = 29.30 μg/ml compared to prednisol-
one (IC50 < 3.1 μg/ml) (Table 1).
Cytotoxicity of the P. africanum extracts on 3T3 Cells
Aqueous and methanol extracts of P. africanum that
showed potential inhibitory effects in various immuno-
logical assays were further tested for their possible tox-
icity effects. Aqueous extract was revealed to be devoid
of toxic effect whereas methanol extract showed moder-
ate level of toxicity on this cell line (IC50 = 6.13 μg/ml)
Table 1 IC50 value of aqueous and methanol extracts of Piptadeniastrum africanum on human whole blood evaluated by luminol
and/or lucigenin amplified chemiluminescence
Oxidative burst (IC50 μg/ml) T-cells proliferation (IC50
μg/ml)
Cytotoxicity on 3T3 Cells (IC50
μg/ml)
Luminol and Zymosan Lucigenin and PMA
WB PMNs MQ WB PMNs MQ









































Prednisolone - - - - - - <3.1 -
Cyclohexamide - - - - - - - 0.1 ± 0.13
The IC50 values are presented as mean ± SD of triplicates. Where WB whole blood, PMNs polymorphonuclear leukocytes, MQ mice peritoneal macrophages
Fig. 1 Effect of crude extracts of Piptadeniastrum africanum on TNF-α (a) and IL-1β (b) secretion levels by THP-1 activated by LPS. Data represent
mean ± SD of triplicates. aP < 0.05, bP < 0.01 when compared with that of the control: PMA + LPS
Mbiantcha et al. BMC Complementary and Alternative Medicine  (2017) 17:111 Page 6 of 16
compared to the cyclohexamide (IC50 = 0.1 μg/ml) used
as the standard cytotoxic drug (Table 1).
In vivo assay
Effect of P. africanum extracts on paw volume
Figure 2 reveals that, extracts of treated groups signifi-
cantly (P < 0.001) lowered the paw volume from the first
day (23.72% and 40.71% inhibition) until the end of
treatment (25.92% and 61.10% inhibition) as compared
to arthritis control group. Aqueous extract treated
groups of 200 mg/kg was less effective, it significantly
(P < 0.01) lowered edema from the 7th day till the last
day of treatment. Indomethacin (5 mg/kg) signifi-
cantly (P < 0.001) reduced the increase of edema in-
duced by CFA from the 3rd day (17.38% inhibition)
till the last day of treatment.
Effect of P. africanum extracts on joint diameter
Joint diameter of rats significantly (P < 0.001) in-
creased in all rats on the groups treated with CFA.
Methanol extract (400 mg/kg) considerably (P < 0.001)
reduced the joint volume from the first day (43.03%
and 49.10% inhibition) till the end of treatment
(64.27% and 72.71% inhibition) as compared to arth-
ritis control group. Aqueous extract or indomethacin
exhibited an important (P < 0.01; P < 0.05) activity
from the 5th day. Joint diameter variation was not
significantly different among the methanol group (400
mg/kg) and healthy control on the 19th day after
CFA injection (Fig. 3).
Effect of P. africanum extracts on mechanical nociceptive
threshold
After the injection of CFA, the mechanical pain
threshold decreased rapidly the first day and contin-
ued to decline gradually way until the 19th day as
shown in the arthritic control. Significant protection
against the mechanical pain was observed, from the
first day (P < 0.05; 27.65% inhibition) until the end of
the treatment for methanol extract (400 mg/kg, P <
0.001; 161.28% inhibition); from the 7th day (P < 0.01;
42.03% inhibition) until the end of the treatment for
aqueous extract (P < 0.001; 66.18% inhibition) and
methanol extract (P < 0.001). However, there was little
improvement observed in aqueous extract (200 mg/
kg) concerning mechanical withdrawal threshold.
Indomethacin (5 mg/kg) showed significant improve-
ment in mechanical withdrawal threshold between the
9th day (45.37% inhibition) and the 17th day (42.53%
inhibition) only (Fig. 4).
Effect of P. africanum extracts on thermal hyperalgesia
(paw withdrawal latency)
Figure 5 indicated the effect of extracts on paw with-
drawal latency after injection of CFA on rat. On this
figure it is observed that, methanol extract signifi-
cantly (P < 0.001) increased the paw withdrawal la-
tency from day 7 (55.87% inhibition) to day 19
(109.08% inhibition), while the same extract (200 mg/
kg) was only significant from day 13 (P < 0.05; 59.34%
inhibition). Indomethacin (5 mg/kg) as the aqueous
extract (200 mg/kg) was not effective in this model.
Fig. 2 Effect of aqueous and methanol extracts of Piptadeniastrum africanum on Edema in FCA-induced arthritis. Values are expressed as mean ±
SEM for six animals and analyses by two-way ANOVA followed by Tukey post-hoc test, γP < 0.001 when compared to healthy control, bP < 0.01,
cP < 0.001 when compared to arthritic control
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Effect of P. africanum extracts on body weight
In untreated rats (arthritis control group), body weight
decreased gradually and became significant (P < 0.01)
from the 11th day compared to the animals of healthy
group. In animals of different groups treated with ex-
tracts (400 and 200 mg/kg) as has indomethacin (5 mg/
kg), change in body weight was not significant (P > 0.05)
throughout the treatment compared to the animals of
healthy groups (Fig. 6).
Effect of P. africanum extracts on arthritic score
Morphological variation materialized by the arthritic score
was significant (P < 0.001) in all animals that received a
sub-plantar administration of CFA. Aqueous and methanol
extracts or indomethacin effectively protected the animals
against the exaggeration of morphological variation ob-
served in untreated animals; this was reflected by a signifi-
cant variation (P < 0.001) of arthritic scores between animal
treated groups and those of the untreated group (Fig. 7).
Fig. 3 Effect of aqueous and methanol extracts of Piptadeniastrum africanum on change in joint diameter in CFA-induced arthritis. Values are
expressed as mean ± SEM for six animals and analyses by two-way ANOVA followed by Tukey post-hoc test, αP < 0.05, βP < 0.01, γP < 0.001 when
compared to healthy control, aP < 0.05, bP < 0.01, cP < 0.001 when compared to arthritic control
Fig. 4 Effect of aqueous and methanol extracts of Piptadeniastrum africanum on mechanical nociceptive threshold in CFA-induced arthritis. Values
are expressed as mean ± SEM for six animals and analyses by two-way ANOVA followed by Tukey post-hoc test, γP < 0.001 when compared to
healthy control, aP < 0.05, bP < 0.01, cP < 0.001 when compared to arthritic control
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Effect of P. africanum extracts on hematological
parameters
Table 2 shows the effects of the extracts on changes in
hematological parameters 19 days after administration of
the CFA. The results of this table reveal that, in animals
of the untreated group, the levels of platelets and WBC
are significantly increased (P < 0.001) while the levels of
RBC, Hb and hematocrit are significantly decreased
compared to animals of healthy group. Moreover, the re-
sults also show that, both extracts or indomethacin sig-
nificantly attenuated these changes in such a way that, at
400 mg/kg, there is no significant variation between
animals of the healthy group and those of the groups
treated with aqueous and methanol extracts.
Effect of P. africanum extracts on various organ weights
The results showed that, liver, spleen and kidney weights
increased considerably (P < 0.01) and thymus weight de-
creased significantly (P < 0.01) in all animals of the un-
treated group. Then, no significant change was observed
between the organ weight of animals treated with ex-
tracts or indomethacin and organ weight of those of
healthy groups (Table 3).
Fig. 5 Effect of aqueous and methanol extracts of Piptadeniastrum africanum on thermal hyperalgesia in CFA-induced arthritis. Values are
expressed as mean ± SEM for six animals and analyses by two-way ANOVA followed by Tukey post-hoc test, αP < 0.05, βP < 0.01, γP < 0.001 when
compared to healthy control, aP < 0.05, bP < 0.01, cP < 0.001 when compared to arthritic control
Fig. 6 Effect of aqueous and methanol extracts of Piptadeniastrum africanum on body weight in CFA-induced arthritis. Values are
expressed as mean ± SEM for six animals and analyses by two-way ANOVA followed by Tukey post-hoc test, βP < 0.01, γP < 0.001 when
compared to healthy control
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Effect of P. africanum extracts on Biochemical parameters
The results in Table 4 show that, in untreated animals
(arthritic control group), serum levels of CRP, RF, AST,
ALT and ALP significantly increased (P < 0.001) and
total protein level significantly decreased (P < 0.001)
compared to the parameters of animals of the healthy
group. In animals treated with extracts or indomethacin,
all biochemical parameters evaluated tend to return to
normal values.
Histology of ankle joints
Histopathology of the ankle joint of healthy control rats
revealed no inflammation, a few lymphocytes infiltra-
tion and no bone necrosis. A massive influx of inflam-
matory cells, cartilage destruction, proliferation of
granulation tissue, lymphocytes infiltration and chronic
inflammation was detected in arthritic control. In con-
trast to these pathological changes, animals having
received aqueous and methanol extracts of P. africa-
num or indomethacin showed significant protection
against necrosis of bones with low influx of inflamma-
tory cells and minimal bone damage compared (Fig. 8).
Discussion
Rheumatoid Arthritis, with symptoms such as swelling
(joints), release of RF (autoantibody), deformity (bone
destruction) and systemic change, is a more frequent
disease that presents major systemic clinically complica-
tions with a high mortality rate in patients compared to
healthy people [57]. In rheumatoid arthritis, swelling of
the synovium due to the proliferation of synovial cells, is
considered the main actor to affection and deterioration
of cartilage with consequences such as the loss of the
protective role of the synovial liquid by altering the
binding properties of proteins in the cartilage [58]. Bone
erosion, associated with increased and prolonged
Fig. 7 Effect of aqueous and methanol extracts of Piptadeniastrum africanum on arthritis score in CFA-induced arthritis. Values are expressed as
mean ± SEM for six animals and analyses by two-way ANOVA followed by Tukey post-hoc test, γP < 0.001 when compared to healthy control,
aP < 0.05, bP < 0.01, cP < 0.001 when compared to arthritic control
Table 2 Influence of the aqueous and methanol extracts of Piptadeniastrum africanum on haematological in CFA-induced
arthritis in rats
Dose (mg/kg) Haemoglobin (g/dl) RBC (million/μl) Hematocrit (%) WBC (109/L) Platelet (109/L)
Healthy control - 14.35 ± 0.45 7.37 ± 0.10 40.80 ± 2.50 7.45 ± 0.45 813.00 ± 40.00
Arthritic control - 8.50 ± 0.20γ 3.99 ± 0.44β 26.75 ± 1.55α 13.25 ± 0.35γ 1815.00 ± 20.00γ
Indomethacin 5 11.60 ± 0.60a 6.05 ± 0.45 35.10 ± 2.20 10.00 ± 0.10b 1074.00 ± 26.00αc
Aqueous extract 200 12.05 ± 0.15a 5.90 ± 0.07 34.60 ± 0.90 8.80 ± 0.80b 1110.00 ± 21.00αc
400 12.15 ± 0.65a 6.53 ± 0.13a 36.85 ± 1.05a 8.40 ± 0.30b 1043.50 ± 4.50c
Methanol extract 200 12.15 ± 0.35a 6.13 ± 0.57 35.00 ± 3.00 10.85 ± 0.85α 1134.00 ± 45.00βc
400 12.45 ± 0.45a 6.89 ± 0.33a 38.60 ± 2.00a 8.85 ± 0.15b 919.00 ± 84.00c
CFA complete Freund’s adjuvant, RBC red blood cell, WBC white blood cell, Hb haemoglobin, MCV mean corpuscular volume, MCH mean corpuscular hemoglobin,
MCHC mean corpuscular hemoglobin concentration. Each value represents the mean ± ESM of six animals. αP < 0.05; βP < 0.01; γP < 0.001 statistically significant
compared to Healthy control. Each value represents the mean ± ESM of 6 animals. aP < 0.05; bP < 0.01; cP < 0.001 statistically significant compared to
Arthritic control
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inflammation, affects 80% of patients and occurs rapidly
[59, 60]. Osteoclast differentiation associated with incur-
sion of cells in the periosteal observed at surface con-
tiguous to articular cartilage are due to cytokines
released in the synovium, principally [61]. In addition,
differentiation and activation of osteoclasts are amplified
by TNF-α and interleukin 1 and 6 [62]. Moreover, in
clinical management, bone erosion can be delayed by in-
hibition of TNF-α, interleukin1 and RANKL [63]. With
the capacity to activate cytokine and chemokine expres-
sion, TNF-α plays an important and decisive role on
endothelial cell adhesion molecules, on angiogenesis, on
suppression of regulatory T-cells, on protection of syn-
ovial fibroblasts and induction of pain [63, 64], while,
cartilage lesions and delayed healing lesions are due to
IL-1β [63].
The studies demonstrate that extracts of P. africanum
inhibited considerably the release of TNF-α and IL-1β.
The results suggest that, the inhibition induced by the
methanol extract on cytokine production possesses clin-
ical significance. Inhibition of release of TNF-α and IL-
1β in presence methanol extract of P. africanum speci-
fies that, this plant possesses compounds which have
anti-inflammatory potential associated with the capacity
to intervene in the immune response. Otherwise, inhibi-
tor effect of new compounds on TNF-α and IL-1β re-
lease is a valid approach because of their major role in
differentiation, growth and death of immune cells and in
the treatment of several inflammatory diseases [65].
To study the effect of aqueous and methanol extracts
of P. africanum another aspect of cellular immune re-
sponse, T-cell proliferation assay was used. The results
show that, these extracts significantly inhibited T-cell
proliferation and dose response relationship was ob-
served, with a significant result for the extracts versus
the positive control (prednisolone) of cell proliferation.
Given that, in the immune response, induction of the
hepatic acute phase protein response and influence of T-
cell responses are part of the assigned functions [66], it
is possible that the inhibitory effect on cell proliferation
was the result of decreased cytokine TNF-α and IL-1β
production. The results suggest that, the compounds of
P. africanum were capable to modulate significantly at
different steps, the immune response of phagocytes and
monocytes.
In pathogenicity of RA, ROS also plays a decisive role;
the lack of control of ROS production improves the
bones and cartilage destruction and activate or suppress
NF-kB [40, 67]. P. africanum showed excellent antioxi-
dant capacity in this study, by significantly inhibiting the
ROS production on whole blood and various phagocytic
cells. It is possible that, this effect might be associated
with the action of the extracts on the NF-kB, given that
the inhibition effect of many compounds on NF-kB
Table 3 Influence of the aqueous and methanol extracts of Piptadeniastrum africanum on organs weight after CFA induced arthritis
Dose (mg/kg) Liver Spleen Kidney Thymus
Healthy control - 6.69 ± 0.16 0.60 ± 0.01 0.91 ± 0.03 0.63 ± 0.04
Arthritic control - 9.19 ± 0.29β 1.27 ± 0.04β 1.35 ± 0.08β 0.31 ± 0.01β
Indomethacin 5 7.45 ± 0.40a 0.81 ± 0.01a 0.98 ± 0.02a 0.54 ± 0.01a
Aqueous extract 200 7.85 ± 0.03 0.90 ± 0.05 1.12 ± 0.01 0.45 ± 0.04
400 6.61 ± 0.09b 0.77 ± 0.05a 0.91 ± 0.09b 0.54 ± 0.02a
Methanol extract 200 7.55 ± 0.30a 0.89 ± 0.01 1.03 ± 0.04a 0.59 ± 0.06b
400 6.55 ± 0.30c 0.74 ± 0.14b 0.93 ± 0.06b 0.62 ± 0.01b
Each value represents the mean ± ESM for six animals and analyses by two-way ANOVA followed by Tukey post-hoc test, βP < 0.01 when compared to healthy
control, aP < 0.05, bP < 0.01, cP < 0.001 when compared to arthritic control
Table 4 Effect of aqueous and methanol extracts of Piptadeniastrum africanum on serum parameters in CFA-induced arthritis in rats
Dose (mg/kg) CRP (mg/l) RF (IU/ml) ALP (U/l) ALT (U/l) AST (U/l) Total protein (g/dl)
Healthy control - 1.69 ± 0.01 - 71.67 ± 2.73 44.73 ± 2.60 41.33 ± 1.86 6.69 ± 0.58
Arthritic control - 6.92 ± 0.24γ 58.00 ± 1.53 471.00 ± 13.23 186.53 ± 11.93γ 132.67 ± 4.10γ 4.83 ± 0.12β
Indomethacin 5 3.84 ± 0.30γc 40.33 ± 1.86c 204.33 ± 46.04βc 123.29 ± 4.41γc 101.67 ± 1.76γc 5.85 ± 0.45α
Aqueous extract 200 6.11 ± 0.32γ 51.67 ± 1.76 416.33 ± 14.33γ 153.76 ± 8.69γa 125.09 ± 2.65γ 5.01 ± 0.07
400 3.98 ± 0.05γc 40.00 ± 1.54c 340.07 ± 26.15γb 121.67 ± 2.03γc 113.77 ± 7.88γa 5.38 ± 0.25
Methanol extract 200 4.29 ± 0.19γc 40.33 ± 0.88c 214.13 ± 4.67γc 119.19 ± 1.45γc 93.33 ± 3.48γc 5.53 ± 0.10
400 3.04 ± 0.04βc 31.00 ± 1.16c 131.60 ± 5.24c 82.21 ± 6.66αc 74.56 ± 5.78γc 6.40 ± 0.26a
CFA complete Freund’s adjuvant, CRP C-reactive protein, RF rheumatoid factor, ALP alkaline phosphatase, AST aminotransferase, ALT alanine aminotransferase. Each
value represents the mean ± ESM for six animals and analyses by two-way ANOVA followed by Tukey post-hoc test, αP < 0.05, βP < 0.01, γP < 0.001 when compared
to healthy control, aP < 0.05, bP < 0.01, cP < 0.001 when compared to arthritic control
Mbiantcha et al. BMC Complementary and Alternative Medicine  (2017) 17:111 Page 11 of 16
phosphorylation considerably suppresses the prolifera-
tion of T-cells [67], but most probably it could be due to
the effect of the presence of some triterpenoids com-
pound; given that, in our previous work, several triterpe-
noids compound like betulinic acid and oleanic acid,
were obtained from the methanol extract of P. africa-
num [68]. These triterpenoids possess anti-inflammatory
and/or antiproliferative properties by the inhibitory ef-
fect of NF-kB phosphorylation [69, 70]. The NF-kB/AP1
axes is important for the inflammatory reaction with
stimulation of the release of TNF-α, IL-1β, NO and
PGE2 [71, 72], the suppression of this axe has a crucial
therapeutic effect [73]. The clinical use of compounds
capable of inhibiting the production of TNF-α and IL-1β
confirmed their importance [74]. Moreover, extracts of
P. africanums show the in vitro inhibition of TNF-α and
IL-1β stimulated by PMA and LPS.
In the present study, the cytotoxic activity of different
extracts of P. africanum was evaluated on 3T3 cell line.
The aqueous extract showed no toxic effect (IC50 = 78.6
μg/ml) whereas the methanol extract showed a moderate
toxicity (IC50 = 6.13 μg/ml). To discover the toxicity of a
compound in humans, and to generally identify toxic
products, in vitro cytotoxicity assays are generally used
[75, 76]. Depending on the test agent used and the cyto-
toxicity assay employed, cytotoxicity tests can give differ-
ent results [77]. Therefore, more than one assay should
be necessary to determine cell viability in in vitro essay
and this would increase the reliability of the results
obtained. However, Assob et al. [35] showed that, ad-
ministered in the acute treatment, the methanol extract
of P. africanum as the aqueous extract causes no death
in rats during acute toxicity showing an LD50 > 5 g/Kg
b.w. which classifies this plant among the nontoxic
plants [78, 79].
The experimental model of polyarthritis induced by
CFA on rat is widely used for preclinical testing of nu-
merous anti arthritic agents [80]. This model, due to its
close similarities with human rheumatoid diseases, is
widely used to evaluate inflammatory disease and valid
as a chronic pain model [81, 82]. In the present study,
extracts of P. africanum treatment showed antiarthritic
potential in all the inflammatory parameters. It signifi-
cantly decreased the inflammation in treated animals by
reducing the paw volume, joint diameter and arthritic
score. In addition, the significant decrease on body
weight observed on animals in the arthritis group was
completely corrected by the extracts. Weight loss is a
powerful predictor of health especially in pathological
states [83]. In the case of RA, weight loss would be due
to muscle loss, poor appetite and metabolic burden of
inflammatory response [84]. On these important parame-
ters, the inhibitory effect of extracts was significantly
higher than that of indomethacin. After injection of CFA,
there occurs a modification in transduction sensitivity of
high threshold nociceptors with as consequence the ap-
pearance of hyperalgesia and allodynia [85]. The analgesic















Fig. 8 Histopathological analysis of ankle joints stained with H&E. a Healthy control shows normal structure with small joint space; b Arthritic
control which shows very large joint space (1), severe hyperplasia (2), granulomas (3), cells infiltration (4) and erosion (5); indomethacin 5 mg/kg
treated (c), aqueous extract 400 mg/kg treated (d) and methanol extract 400 mg/kg treated (e) show a decrease in joint space (1) and a
reduction of cells infiltration
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arthritis is also marked as evident by the significant de-
crease of hyperalgesia (thermal and mechanical).
In arthritic patients, serum CRP, prototype biomarker
of systemic inflammation for acute phase reactants with
a level that increases rapidly during inflammatory pro-
cesses, is used as a useful serum biomarker for evaluat-
ing the active inflammation [86, 87]. Serum rheumatoid
factor (RF) is an immunoglobulin molecule considered
as "non self” capable of eliciting a reaction of the im-
mune system [88]. In the pathogenesis of RA, abnormal
changes in serum level of RF and CRP could be recog-
nized as a strong indicator of RA [89]. CFA induced
arthritis in rats increased the CRP and RF level as evi-
denced in the inflammatory process as shown by the re-
sults of the arthritis control group in this study. A
significant (P < 0.001) decrease of RF and CRP level was
observed after treatment with aqueous and methanol ex-
tracts of P. africanum.
To evaluate anti-arthritic activity of a drug, the
level of AST ALT ALP and total protein provide an
excellent and simple tool. Aminotransferases and ALP
which are good indices of liver as kidney impairment,
their activities significantly increased in adjuvant arth-
ritis in rats [90]. In addition to the fact that the activ-
ity of serum alkaline phosphatase increased in
pathogenicity of RA, the serum level of this enzyme
like that of AST would play an important role in the
release of biologically active compounds (bradykinins)
in the inflammatory process [91, 92]. This enzyme be-
ing liberated into circulation during the bone forma-
tion and resorption, will be involved in localized bone
loss as bone erosion and periarticular osteopenia [93].
In addition, in about 30% of patients with RA, a sig-
nificant elevation of serum ALT levels was observed
[94]. In this study, arthritic rats showed significantly
higher values of serum ALP, AST and ALT, while in
animals with the different treatments (P. africanum
or indomethacin), increased levels of these enzymes
was significantly attenuated.
Suppressive activity of the extracts on fundamental
molecules (TNF-α and T-cells) which play an essen-
tial role in the pathogenesis of arthritis [92] ob-
served in vitro could justify the net suppressive
effect on inflammation and hyperalgesia. This effect
could be at the origin of the observation of de-
creased levels of CRP and RF in serum, also in the
maintenance of animal body weight, given that TNF-
α plays a key role in the genesis of asthenia and
weight loss in RA [11]. The decrease in edema and
joint diameter observed macroscopically and histo-
pathologically followed by increase in latency time of
pain threshold and thermal hyperalgesia clearly re-
veals the anti-inflammatory, antihyperalgesia and
anti-arthritis potential of P. africanum.
Conclusion
After this study, we can say that P. africanum is a plant
rich in compounds possessing anti-inflammatory, antihy-
peralgesic and/or anti-arthritic potential. These proper-
ties were evaluated by in vivo study using a model of
CFA induced on rats. The activity of the extracts of this
plant is strongly justified by its effect on the immune
system and/or inhibitory properties to the release of
pro-inflammatory mediators as observed in the in vitro
study. These results justify the use of this plant for de-
cades in traditional treatment against inflammatory dis-
eases including arthritis and classify this plant among
the potential candidates for the isolation of novel anti-
inflammatory and/or anti-arthritic products.
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